New patent expiration for Sprout Pharms ADDYI drug – DrugPatentWatch

Less than a minute

Annual Drug Patent Expiration for ADDYI

Addyi is a drug marketed by Sprout Pharms and is included in one NDA. It is available from a single supplier. There are four patents protecting this drug.

This drug has seventy-six patent family members in thirty-one countries.

The generic ingredient in ADDYI is flibanser. One registered supplier for this compound. Additional details are available on the flibanserin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com